dismiss

Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

RadioMedix and Vect-Horus to develop brain theranostic agent for brain cancer Provide diagnosis and treatment of Glioblastoma Multiforme (GBM)

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

DOE to cut Moly-99 deals with four US firms Could be as much as $15 million per company, with partners matching awarded amounts

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

Dennis Durmis MITA names chair of board of directors

Researchers find new PET tracer that better detects melanoma than 18F-FDG 18F-P3BZA could become the new gold standard

RadioMedix scores $2 million contract for Targeted Alpha-emitter therapy Treatment for neuroendocrine tumors

FDA clears United Imaging's total-body PET scanner Creating 3D images of entire human body in 15-30 seconds

FDA clears MIM SurePlan molecular radiotherapy software Can measure the absorbed dose from MRT for individual patients

Rob Beanlands ASNC names president for 2019

New imaging diagnosis for cardiac sarcoidosis

Fatty diet may improve diagnosis of lethal heart condition with PET/CT

by John W. Mitchell , Senior Correspondent
Researchers at the University of Illinois at Chicago (UIC) think they have found a much better way to find a sneaky condition that disproportionately kills African Americans.

"So far, active cardiac sarcoidosis (CS) has been a diagnostic challenge to physicians and scientists and is a potentially lethal disease, posing threats to patients," Dr. Yang Lu, lead author and chief, nuclear medicine & PT/CT, UIC, told HCB News. "Clinically, the presentation of CS is nonspecific and can range from asymptomatic, to chest pain, to abnormal EKG, to sudden death."

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



According to Lu, until this study, which has just been published online at Clinical Nuclear Medicine, there was no well-accepted, "good" imaging test to diagnose CS. The condition is especially prevalent in African Americans. Past diagnosis has been made by a combination of several diagnostic tests, but is often ambiguous.

In the study, patients were instructed to eat a high fat and protein, low sugar and carbohydrate diet for 72 hours before receiving a hybrid radio tracer (fludeoxyglucose or FDG) under PET/CT scan. The FDG collected in high-metabolic cells that use lots of sugar for energy, including cancer cells and cells affected by inflammation, such as that caused by CS.

Sarcoidosis is an inflammatory disease that attacks multiple organs. These include the lymph nodes, lungs and heart. The heart strain associated with CS can be deadly, and is particularly difficult to diagnose.

Lu said that when they started the study, patients were put on the diet for 24 hours. But this protocol only yielded clearer CS indications in about half the studies. Then a patient arrived a day late.

"The patient had been following the high-fat, low-sugar diet for two days at that point instead of the usual 24 hours," Lu said.

When they scanned the patient, the areas where the heart picked up the FDG were much clearer, and showed active CS. These findings were consistent with the abnormal CS findings from the patient's MR scan. Based on that patient, they set the dietary protocol at 72 hours.

When the team compared study results of 215 tests they found that 42 percent of the patients on the 24-hour protocol had "indeterminate" results. However, only four percent of the patients on the 72-hour protocol had indeterminate results. For the other 96 percent of patients, the radiologists were able to say with a high degree of confidence whether or not the patients suffered from CS.

"This protocol is simple and straightforward [and] might change the way we use FDG PET/CT for a CS diagnosis," Lu said.

Back to HCB News
  Pages: 1

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED